1. Home
  2. Browse
  3. National Institutes of Health
  4. PAR-27-012

PAR-27-012National Institutes of HealthUG3

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Mar 18, 2026

Official announcement on Grants.gov · opens the funder's page. Always confirm dates there.

Or read the full text and all 3 review criteria here, free with an account. Create free account

Summary

NOFO Research Objectives This NOFO supports applications to develop and conduct a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials. Clinical trials supported by this NOFO include Phase II and above clinical trials that will enroll participants from two or more recruitment sites…

Related NIH announcements6

Other open UG3 announcements on related subjects, with at least two weeks to go.

Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)

PAR-25-311National Institutes of Health3 review criteria on file

$6.3M

Community-Based Participatory Research to Advance Data and Practice Transformation (ADAPT) for Optimizing Oral Health for All (UG3/UH3 Clinical Trial Optional)

PAR-27-015National Institutes of Health3 review criteria on file

$300k

NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-188National Institutes of Health3 review criteria on file

$500k

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

PAR-25-057National Institutes of Health6 review criteria on file

—

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

PAR-25-226National Institutes of Health3 review criteria on fileagency framework

—

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)

PAR-25-052National Institutes of Health3 review criteria on fileagency framework

—

The full announcement, free with an account

  • The full announcement text, not just the first two sentences
  • All 3 review criteria reviewers score this against, extracted from this announcement

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
  • Funded precedents: what similar NIH projects received, from the award records in NIH RePORTER
  • A Reviewer Scorecard of your draft against these criteria

No card required. Browsing is free.

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Instrumentation, Infrastructure), with at least two weeks to apply.

Everything open tagged Instrumentation

Source record: https://www.grants.gov/search-results-detail/358851Via Grants.gov. Last checked against the source . Always confirm dates with the funder.